These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Blask DE; Sauer LA; Dauchy RT; Holowachuk EW; Ruhoff MS; Kopff HS Cancer Res; 1999 Sep; 59(18):4693-701. PubMed ID: 10493527 [TBL] [Abstract][Full Text] [Related]
3. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women. Blask DE; Dauchy RT; Brainard GC; Hanifin JP Integr Cancer Ther; 2009 Dec; 8(4):347-53. PubMed ID: 20042410 [TBL] [Abstract][Full Text] [Related]
4. Light contamination during the dark phase in "photoperiodically controlled" animal rooms: effect on tumor growth and metabolism in rats. Dauchy RT; Sauer LA; Blask DE; Vaughan GM Lab Anim Sci; 1997 Oct; 47(5):511-8. PubMed ID: 9355094 [TBL] [Abstract][Full Text] [Related]
5. Antineoplastic effects of melatonin on a rare malignancy of mesenchymal origin: melatonin receptor-mediated inhibition of signal transduction, linoleic acid metabolism and growth in tissue-isolated human leiomyosarcoma xenografts. Dauchy RT; Blask DE; Dauchy EM; Davidson LK; Tirrell PC; Greene MW; Tirrell RP; Hill CR; Sauer LA J Pineal Res; 2009 Aug; 47(1):32-42. PubMed ID: 19486272 [TBL] [Abstract][Full Text] [Related]
6. Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin. Blask DE; Dauchy RT; Sauer LA; Krause JA Carcinogenesis; 2004 Jun; 25(6):951-60. PubMed ID: 14754876 [TBL] [Abstract][Full Text] [Related]
7. Lighting for the human circadian clock: recent research indicates that lighting has become a public health issue. Pauley SM Med Hypotheses; 2004; 63(4):588-96. PubMed ID: 15325001 [TBL] [Abstract][Full Text] [Related]
8. 13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid-dependent growth in rat hepatoma 7288CTC in vivo. Sauer LA; Dauchy RT; Blask DE; Armstrong BJ; Scalici S Cancer Res; 1999 Sep; 59(18):4688-92. PubMed ID: 10493526 [TBL] [Abstract][Full Text] [Related]
9. Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Dauchy RT; Blask DE; Sauer LA; Brainard GC; Krause JA Cancer Lett; 1999 Oct; 144(2):131-6. PubMed ID: 10529012 [TBL] [Abstract][Full Text] [Related]
10. Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression. Blask DE; Dauchy RT; Sauer LA; Krause JA; Brainard GC Breast Cancer Res Treat; 2003 Jun; 79(3):313-20. PubMed ID: 12846415 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of fatty acid transport and proliferative activity in tissue-isolated human squamous cell cancer xenografts perfused in situ with melatonin or eicosapentaenoic or conjugated linoleic acids. Dauchy RT; Dauchy EM; Davidson LK; Krause JA; Lynch DT; Tirrell PC; Tirrell RP; Sauer LA; Van der Riet P; Blask DE Comp Med; 2007 Aug; 57(4):377-82. PubMed ID: 17803052 [TBL] [Abstract][Full Text] [Related]
12. Dietary factors and growth and metabolism in experimental tumors. Sauer LA; Blask DE; Dauchy RT J Nutr Biochem; 2007 Oct; 18(10):637-49. PubMed ID: 17418560 [TBL] [Abstract][Full Text] [Related]
13. Human cancer xenograft perfusion in situ in rats: a new perfusion system that minimizes delivery time and maintains normal tissue physiology and responsiveness to growth-inhibitory agents. Dauchy EM; Dauchy RT; Davidson LK; Lynch DT; Krause JA; Blue LM; Sauer LA; Blask DE J Am Assoc Lab Anim Sci; 2006 May; 45(3):38-44. PubMed ID: 16642969 [TBL] [Abstract][Full Text] [Related]
14. Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Shah PN; Mhatre MC; Kothari LS Cancer Res; 1984 Aug; 44(8):3403-7. PubMed ID: 6430548 [TBL] [Abstract][Full Text] [Related]
15. The light-dark regimen and cancer development. Anisimov VN Neuro Endocrinol Lett; 2002 Jul; 23 Suppl 2():28-36. PubMed ID: 12163845 [TBL] [Abstract][Full Text] [Related]
16. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Blask DE; Brainard GC; Dauchy RT; Hanifin JP; Davidson LK; Krause JA; Sauer LA; Rivera-Bermudez MA; Dubocovich ML; Jasser SA; Lynch DT; Rollag MD; Zalatan F Cancer Res; 2005 Dec; 65(23):11174-84. PubMed ID: 16322268 [TBL] [Abstract][Full Text] [Related]
17. Melatonin and mammary pathological growth. Cos S; Sánchez-Barceló EJ Front Neuroendocrinol; 2000 Apr; 21(2):133-70. PubMed ID: 10764528 [TBL] [Abstract][Full Text] [Related]
18. Mechanism for the antitumor and anticachectic effects of n-3 fatty acids. Sauer LA; Dauchy RT; Blask DE Cancer Res; 2000 Sep; 60(18):5289-95. PubMed ID: 11016660 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic actions of melatonin in cancer: possible mechanisms. Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150 [TBL] [Abstract][Full Text] [Related]
20. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Blask DE; Dauchy RT; Sauer LA Endocrine; 2005 Jul; 27(2):179-88. PubMed ID: 16217131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]